| 英文别名 |
Glycine, N-2-naphthalenyl-, [(3,5-dibromo-2,4-dihydroxyphenyl)methylene]hydrazide;N-2-Naphthalenyl-glycine 2-[(3,5-Dibromo-2,4-dihydroxyphenyl)methylene]hydrazide;CFTR Inhibitor II;CFTR Inhibitor II, GlyH-101;GLYH 101;GlyH-101;N'-[(3,5-dibromo-4-hydroxy-6-oxocyclohexa-2,4-dien-1-ylidene)methyl]-2-(naphthalen-2-ylamino)acetohydrazide;N-2-Naphthalenyl-gly;N-2-Naphthalenylglycine [(3,5-dibromo-2,4-dihydroxyphenyl)methylene]hydrazide;N'-{[(1E)-3,5-dibromo-4-hydroxy-6-oxocyclohexa-2,4-dien-1-ylidene]methyl}-2-[(naphthalen-2-yl)amino]acetohydrazide;J-018908;(Naphthalen-2-ylamino)-acetic acid (3,5-dibromo-2,4-dihydroxy-benzylidene)-hydrazide;AC-32676;CHEMBL1221576;N-[(E)-(3,5-dibromo-2,4-dihydroxyphenyl)methylideneamino]-2-(naphthalen-2-ylamino)acetamide;AKOS026750493;Glycine, n-2-naphthalenyl-, 2-[(3,5-dibromo-2,4-dihydroxyphenyl)methylene]hydrazide;BDBM50324733;CFTR Inhibitor II, GlyH-101 - CAS 328541-79-3;EX-A2041;N'-(3,5-dibromo-2,4-dihydroxybenzylidene)-2-(naphthalen-2-ylamino)acetohydrazide;N''-(3,5-dibromo-2,4-dihydroxybenzylidene)-2-(naphthalen-2-ylamino)acetohydrazide;CCG-269637;AKOS025148694;CHEBI:191117;AKOS032947331;N'-[(3,5-dibromo-2,4-dihydroxyphenyl)methylidene]-2-[(naphthalen-2-yl)amino]acetohydrazide;328541-79-3;SCHEMBL12648530;HY-18336;S8094;AS-74016 |
